$30 million invested in new pharmaceutical production facility in Herat

A significant investment of $30 million has been announced for the establishment of a new pharmaceutical production facility in Herat, Afghanistan. This development is expected to enhance the local economy by creating jobs and improving access to essential medications. The facility aims to produce a range of pharmaceutical products, contributing to the country’s self-sufficiency in healthcare. Local officials and stakeholders have expressed optimism about the project, highlighting its potential to boost the pharmaceutical sector and reduce reliance on imported drugs. The investment aligns with broader efforts to strengthen Afghanistan's healthcare infrastructure and promote economic growth in the region. Further details regarding the timeline for construction and production capabilities are anticipated as the project progresses.